SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kevin T. McVary, Steven N. Gange, Marc C. Gittelman, Kenneth A. Goldberg, Kalpesh Patel, Neal D. Shore, Richard M. Levin, Michael Rousseau, J. Randolf Beahrs, Jed Kaminetsky, Barrett E. Cowan, Christopher H. Cantrill, Lance A. Mynderse, James C. Ulchaker, Thayne R. Larson, Christopher M. Dixon, Claus G. Roehrborn, Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study, The Journal of Sexual Medicine, 2016,

    CrossRef

  2. 2
    Fouad Aoun, Anthony Kallas Chemaly, Simone Albisinni, Marc Zanaty, Thierry Roumeguere, In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction, Asian Pacific Journal of Cancer Prevention, 2016, 17, 1, 1

    CrossRef

  3. 3
    I A Korneyev, T A Alexeeva, S H Al-Shukri, A N Bernikov, A A Erkovich, A A Kamalov, M I Kogan, V N Pavlov, V N Zhuravlev, D Y Pushkar, Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study, International Journal of Impotence Research, 2016, 28, 2, 74

    CrossRef

  4. 4
    Maoqiang Wang, Liping Guo, Feng Duan, Kai Yuan, Guodong Zhang, Kai Li, Jieyu Yan, Yan Wang, Haiyan Kang, Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates, BJU International, 2016, 117, 1
  5. 5
    Giorgio I. Russo, Tommaso Castelli, Salvatore Privitera, Eugenia Fragalà, Vincenzo Favilla, Giulio Reale, Daniele Urzì, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, Sebastiano Cimino, Giuseppe Morgia, Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms, BJU International, 2015, 116, 5
  6. 6
    S. Faithfull, A. Lemanska, P. Aslet, N. Bhatt, J. Coe, L. Drudge-Coates, M. Feneley, R. Glynn-Jones, M. Kirby, S. Langley, T. McNicholas, J. Newman, C. C. Smith, A. Sahai, E. Trueman, H. Payne, Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies, International Journal of Clinical Practice, 2015, 69, 10
  7. 7
    Graham Jackson, Mike G. Kirby, Ray Rosen, Lower urinary tract symptoms (LUTS) – an independent risk factor for cardiovascular disease (CVD), BJU International, 2015, 116, 5
  8. 8
    D. Ilo, M. Raluy-Callado, P. Graham-Clarke, R. Sadasivan, J. Birt, R. Donaldson, E. Zhu, M. G. Kirby, D. Neasham, Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study, International Journal of Clinical Practice, 2015, 69, 8
  9. 9
    Albert Haddad, Michel Jabbour, Muhammad Bulbul, Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review, Arab Journal of Urology, 2015, 13, 3, 155

    CrossRef

  10. 10
    V Favilla, G I Russo, G Reale, S Leone, T Castelli, S La Vignera, R A Condorelli, A E Calogero, S Cimino, G Morgia, Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification, International Journal of Impotence Research, 2015, 27, 6, 201

    CrossRef

  11. 11
    Mao Qiang Wang, Li Ping Guo, Guo Dong Zhang, Kai Yuan, Kai Li, Feng Duan, Jie Yu Yan, Yan Wang, Hai Yan Kang, Zhi Jun Wang, Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population, BMC Urology, 2015, 15, 1

    CrossRef

  12. 12
    K. B. Egan, M. Suh, R. C. Rosen, A. L. Burnett, X. Ni, D. G. Wong, K. T. McVary, Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001–2008, International Journal of Clinical Practice, 2015, 69, 11
  13. 13
    Benjamin Gonzalez-Sanchez, Jesus Cendejas-Gomez, J. Alejandro Rivera-Ramirez, Jaime O. Herrera-Caceres, Daniel Olvera-Posada, Christian I. Villeda-Sandoval, Ricardo A. Castillejos-Molina, Guillermo Feria-Bernal, Arturo Garcia-Mora, Francisco Rodriguez-Covarrubias, The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS), World Journal of Urology, 2015,

    CrossRef

  14. 14
    Hui Meng Tan, Wei Phin Tan, Jun Hoe Wong, Christopher Chee Kong Ho, Chin Hai Teo, Chirk Jenn Ng, Men's Health Index: A Pragmatic Approach to Stratifying and Optimizing Men's Health, Korean Journal of Urology, 2014, 55, 11, 710

    CrossRef

  15. 15
    C. C. Carson, M. Rosenberg, J. Kissel, D. G. Wong, Tadalafil – a therapeutic option in the management of BPH-LUTS, International Journal of Clinical Practice, 2014, 68, 1
  16. 16
    M. T. Rosenberg, Peanut butter and jelly, International Journal of Clinical Practice, 2013, 67, 7
  17. 17
    Hyun Jun Park, Ji Eon Joanne Won, Sebastian Sorsaburu, Paul David Rivera, Seung Wook Lee, Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil, The World Journal of Men's Health, 2013, 31, 3, 193

    CrossRef